Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Mayo Clinic
- Study ID
- NCT07243067
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Chromophobe Renal Cell Carcinoma
- Clear-cell Renal Cell Carcinoma
- Kidney Cancer
- Papillary Renal Cell Carcinoma
- Renal Cell Carcinoma
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Proteomic profiling of urinary EVs — OTHEREV isolation and mass spectrometry.
- Blood sample collection — PROCEDUREBlood samples collected pre- and post-nephrectomy
Study Details
This is a correlative (lab-based) study aiming to identify protein markers in urine extracellular vesicles (EVs) that can be used to develop non-invasive molecular tests for patients with renal cell carcinoma (RCC). Aim 1 will use urine collected previously in biorepository. Aim 2 will prospectively collect blood specimens pre and post nephrectomy.
Key Dates
- Start date
- Jul 15, 2026
- Status verified
- Feb 2026
- Primary completion
- Apr 30, 2027
- Completion
- Apr 30, 2027
Study Design
- Enrollment
- 300 participants (estimated)
Arms
- Arm: Clear-cell RCCParticipants with clear-cell RCC
- Arm: Papillary RCCParticipants with papillary RCC
- Arm: Chromophobe RCCParticipants with chromophobe RCC
- Arm: Benign Renal TumorParticipants with benign renal tumors
Primary Outcome Measure
Differentiate tumor-derived extracellular vesicle (tdEV) surface proteins expressed in benign vs malignant renal tumors [ Time Frame: Baseline ]
Central Contacts
- Clinical Trials Referral Office855-776-0015
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic in Rochester | Rochester | Minnesota | 55905 | Fabrice Lucien-Matteoni, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Rochester, MN
Related Studies
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary TumorsPHASE2 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy EvaluationRecruiting · Guardant Health, Inc. · Birmingham, Alabama
- A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell CarcinomaPHASE1 · Recruiting · HiberCell, Inc. · Tucson, Arizona